AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa and ...
2-Year U.S. Treasury Note Continuous Contract $104.398 0.020 0.02% 5-Year U.S. Treasury Note Continuous Contract $109.375 0.039 0.04% 10-Year U.S. Treasury Note Continuous Contract $112.594 0.016 0.01 ...
Create a professional email identity by setting up your custom email domain. This guide walks you through every step to get your personalized email address up and running. Creating your own email ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback